Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn L Schwertfeger

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Current Drug Targets|July 16, 2009
Fibroblast growth factors in development and cancer: insights from the mammary and prostate glandsKathryn L Schwertfeger
Journal of Mammary Gland Biology and Neoplasia|December 10, 2025
Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic PerspectiveJennifer E Tuokkola, Kathryn L Schwertfeger
Current Drug Targets|June 16, 2010
Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeuticsJodi E Goldberg, Kathryn L Schwertfeger
Journal of Mammary Gland Biology and Neoplasia|August 24, 2010
Immune cell location and function during post-natal mammary gland developmentJohanna R Reed, Kathryn L Schwertfeger
Molecular Cancer Research : MCR|August 16, 2012
Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent mannerLaura R Bohrer, Kathryn L Schwertfeger
Mediators of Inflammation|February 18, 2016
Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast CancerNicholas J Brady, Pavlina Chuntova, Kathryn L Schwertfeger
Molecular Endocrinology (Baltimore, Md.)|February 8, 2007
Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transitionWa Xian, Kathryn L Schwertfeger, Jeffrey M Rosen
Current Opinion in Physiology|July 1, 2026
Mammary gland development and function in maternal obesity and gestational diabetesBrian Akhaphong, Emilyn U Alejandro, Kathryn L Schwertfeger
Developmental Biology|June 14, 2017
STAT5 deletion in macrophages alters ductal elongation and branching during mammary gland developmentNicholas J Brady, Michael A Farrar, Kathryn L Schwertfeger
Scientific Reports|April 3, 2023
Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitorsAditi S Bapat, Christine H O'Connor, Kathryn L Schwertfeger
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Current Drug Targets|July 16, 2009
Fibroblast growth factors in development and cancer: insights from the mammary and prostate glandsKathryn L Schwertfeger
Journal of Mammary Gland Biology and Neoplasia|December 10, 2025
Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic PerspectiveJennifer E Tuokkola, Kathryn L Schwertfeger
Current Drug Targets|June 16, 2010
Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeuticsJodi E Goldberg, Kathryn L Schwertfeger
Journal of Mammary Gland Biology and Neoplasia|August 24, 2010
Immune cell location and function during post-natal mammary gland developmentJohanna R Reed, Kathryn L Schwertfeger
Molecular Cancer Research : MCR|August 16, 2012
Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent mannerLaura R Bohrer, Kathryn L Schwertfeger
Mediators of Inflammation|February 18, 2016
Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast CancerNicholas J Brady, Pavlina Chuntova, Kathryn L Schwertfeger
Molecular Endocrinology (Baltimore, Md.)|February 8, 2007
Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transitionWa Xian, Kathryn L Schwertfeger, Jeffrey M Rosen
Current Opinion in Physiology|July 1, 2026
Mammary gland development and function in maternal obesity and gestational diabetesBrian Akhaphong, Emilyn U Alejandro, Kathryn L Schwertfeger
Developmental Biology|June 14, 2017
STAT5 deletion in macrophages alters ductal elongation and branching during mammary gland developmentNicholas J Brady, Michael A Farrar, Kathryn L Schwertfeger
Scientific Reports|April 3, 2023
Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitorsAditi S Bapat, Christine H O'Connor, Kathryn L Schwertfeger
Pageof 6